Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Garg

Showing results (491-500 of 530) with videos related to

Pageof 53
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 27, 2010
A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)A Durrbach, J M Pestana, T Pearson, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|February 18, 2025
A cross-cultural study translating and validating the COMPAT-SF pain questionnaire in Telugu, Bengali and HindiM Unnisa, A Agarwal, C Peddapulla, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 27, 2010
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)F Vincenti, B Charpentier, Y Vanrenterghem, et al.
Clinical Pharmacology in Drug Development|June 17, 2016
A Phase 1 Dose-Escalation Study of ASP2409, a Selective T-Cell Costimulation Inhibitor, in Stable Rheumatoid Arthritis Patients on Methotrexate TherapyWenhui Zhang, Robert M Kernstock, Erik E Karrer, et al.
Newborn (Clarksville, Md.)|November 17, 2023
Clinical Correlates of Cholestasis in Preterm Infants with Surgical Necrotizing EnterocolitisParvesh Mohan Garg, Isabella Pittman, Joe Yi, et al.
Psychiatry Research|April 18, 2001
Reproducibility of in vivo brain measures of 5-HT2A receptors with PET andJ C Soares, C H van Dyck, P Tan, et al.
Annals of the Rheumatic Diseases|October 7, 2021
B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trialRichard A Furie, Gustavo Aroca, Matthew D Cascino, et al.
Lupus Science & Medicine|June 17, 2026
Phase Ib, multicentre, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneously administered mosunetuzumab in participants with systemic lupus erythematosusElsa Martins, Vishala L Chindalore, X Rebecca Sheng, et al.
Rheumatology and Therapy|August 15, 2019
Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension StudyMark C Genovese, Maria W Greenwald, Sergio R Gutierrez-Ureña, et al.
The New England Journal of Medicine|June 5, 2026
Obinutuzumab or Tacrolimus in Primary Membranous NephropathyFernando C Fervenza, Fan Fan Hou, Chuan-Ming Hao, et al.
Pageof 53

Showing results (491-500 of 530) with videos related to

Sort By:
Pageof 53
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 27, 2010
A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)A Durrbach, J M Pestana, T Pearson, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|February 18, 2025
A cross-cultural study translating and validating the COMPAT-SF pain questionnaire in Telugu, Bengali and HindiM Unnisa, A Agarwal, C Peddapulla, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 27, 2010
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)F Vincenti, B Charpentier, Y Vanrenterghem, et al.
Clinical Pharmacology in Drug Development|June 17, 2016
A Phase 1 Dose-Escalation Study of ASP2409, a Selective T-Cell Costimulation Inhibitor, in Stable Rheumatoid Arthritis Patients on Methotrexate TherapyWenhui Zhang, Robert M Kernstock, Erik E Karrer, et al.
Newborn (Clarksville, Md.)|November 17, 2023
Clinical Correlates of Cholestasis in Preterm Infants with Surgical Necrotizing EnterocolitisParvesh Mohan Garg, Isabella Pittman, Joe Yi, et al.
Psychiatry Research|April 18, 2001
Reproducibility of in vivo brain measures of 5-HT2A receptors with PET andJ C Soares, C H van Dyck, P Tan, et al.
Annals of the Rheumatic Diseases|October 7, 2021
B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trialRichard A Furie, Gustavo Aroca, Matthew D Cascino, et al.
Lupus Science & Medicine|June 17, 2026
Phase Ib, multicentre, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneously administered mosunetuzumab in participants with systemic lupus erythematosusElsa Martins, Vishala L Chindalore, X Rebecca Sheng, et al.
Rheumatology and Therapy|August 15, 2019
Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension StudyMark C Genovese, Maria W Greenwald, Sergio R Gutierrez-Ureña, et al.
The New England Journal of Medicine|June 5, 2026
Obinutuzumab or Tacrolimus in Primary Membranous NephropathyFernando C Fervenza, Fan Fan Hou, Chuan-Ming Hao, et al.
Pageof 53